[1] |
Shang SL,Zhou D,Ya JY,et al. Progress in moyamoya disease[J]. Neurosurg Rev,2020,43(2): 371-382. doi: 10.1007/s10143-018-0994-5
|
[2] |
Ihara M,Yamamoto Y,Hattori Y,et al. Moyamoya disease:diagnosis and interventions[J]. Lancet Neurol,2022,21(8): 747-758. doi: 10.1016/S1474-4422(22)00165-X
|
[3] |
Jauch EC,Saver JL,Adams HP Jr,et al. Guidelines for the early management of patients with acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke,2013,44(3): 870-947. doi: 10.1161/STR.0b013e318284056a
|
[4] |
Liebeskind DS. Collateral circulation[J]. Stroke,2003,34(9): 2279-2284. doi: 10.1161/01.STR.0000086465.41263.06
|
[5] |
Maguida G, Shuaib A. Collateral circulation in ischemic stroke: an updated review[J/OL].https: //doi.org/10.5853/jos.2022.02936.
|
[6] |
中国卒中学会脑血流与代谢分会. 缺血性卒中脑侧支循环评估与干预中国指南(2017)[J]. 中华内科杂志,2017,56(6): 460-471. doi: 10.3760/cma.j.issn.0578-1426.2017.06.016
|
[7] |
Hendrikx G,Vöö S,Bauwens M,et al. SPECT and PET imaging of angiogenesis and arteriogenesis in pre-clinical models of myocardial ischemia and peripheral vascular disease[J]. Eur J Nucl Med Mol Imaging,2016,43(13): 2433-2447. doi: 10.1007/s00259-016-3480-8
|
[8] |
Fang H,Song B,Cheng B,et al. Compensatory patterns of collateral flow in stroke patients with unilateral and bilateral carotid stenosis[J]. BMC Neurol,2016,16: 39. doi: 10.1186/s12883-016-0560-0
|
[9] |
Fujimura M,Tominaga T,Kuroda S,et al. 2021 Japanese guidelines for the management of moyamoya disease:guidelines from the research committee on moyamoya disease and Japan stroke society[J]. Neurol Med Chir (Tokyo),2022,62(4): 165-170. doi: 10.2176/jns-nmc.2021-0382
|
[10] |
刘文华,倪冠中,黄显军,等. 成年型烟雾病侧支循环的分布模式[J]. 中华神经科杂志,2012,45(3): 149-153. doi: 10.3760/cma.j.issn.1006-7876.2012.03.002
|
[11] |
Abumiya T,Fujimura M. The pathogenetic mechanism for moyamoya vasculopathy including a possible trigger effect of increased flow velocity[J]. JMA J,2023,6(1): 16-24.
|
[12] |
Zhao M,Zhang D,Wang S,et al. The collateral circulation in moyamoya disease:a single-center experience in 140 pediatric patients[J]. Pediatr Neurol,2017,77: 78-83. doi: 10.1016/j.pediatrneurol.2017.08.016
|
[13] |
Kim SJ,Son TO,Kim KH,et al. Neovascularization precedes occlusion in moyamoya disease:angiographic findings in 172 pediatric patients[J]. Eur Neurol,2014,72(5/6): 299-305.
|
[14] |
Poggesi A,Pasi M,Pescini F,et al. Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease:a review[J]. J Cereb Blood Flow Metab,2016,36(1): 72-94. doi: 10.1038/jcbfm.2015.116
|
[15] |
Vinci MC,Carulli E,Rurali E,et al. The long telling story of “endothelial progenitor cells”:where are we at now?[J]. Cells,2022,12(1): 112. doi: 10.3390/cells12010112
|
[16] |
Tinelli F,Nava S,Arioli F,et al. Vascular remodeling in moyamoya angiopathy:from peripheral blood mononuclear cells to endothelial cells[J]. Int J Mol Sci,2020,21(16): 5763. doi: 10.3390/ijms21165763
|
[17] |
Alwjwaj M,Kadir RRA,Bayraktutan U. The secretome of endothelial progenitor cells:a potential therapeutic strategy for ischemic stroke[J]. Neural Regen Res,2021,16(8): 1483-1489. doi: 10.4103/1673-5374.303012
|
[18] |
Gürler G,Soylu KO,Yemisci M. Importance of pericytes in the pathophysiology of cerebral ischemia[J]. Noro Psikiyatr Ars,2022,59(Suppl 1): S29-S35.
|
[19] |
Dordoe C,Chen KY,Huang WT,et al. Roles of fibroblast growth factors and their therapeutic potential in treatment of ischemic stroke[J]. Front Pharmacol,2021,12: 671131. doi: 10.3389/fphar.2021.671131
|
[20] |
Ma YH,Zechariah A,Qu Y,et al. Effects of vascular endothelial growth factor in ischemic stroke[J]. J Neurosci Res,2012,90(10): 1873-1882. doi: 10.1002/jnr.23088
|
[21] |
Manuel GE,Johnson T,Liu D. Therapeutic angiogenesis of exosomes for ischemic stroke[J]. Int J Physiol Pathophysiol Pharmacol,2017,9(6): 188-191.
|
[22] |
Li JC,Jin MY,Sun XY,et al. Imaging of moyamoya disease and moyamoya syndrome:current status[J]. J Comput Assist Tomogr,2019,43(2): 257-263. doi: 10.1097/RCT.0000000000000834
|
[23] |
Guo X,Yuan XX,Gao LY,et al. Encephaloduroarteriosynangiosis (EDAS) treatment of moyamoya syndrome:evaluation by computed tomography perfusion imaging[J]. Eur Radiol,2021,31(11): 8364-8373. doi: 10.1007/s00330-021-07960-4
|
[24] |
Li JZ,Zhang Y,Yin D,et al. CT perfusion-based delta-radiomics models to identify collateral vessel formation after revascularization in patients with moyamoya disease[J]. Front Neurosci,2022,16: 974096. doi: 10.3389/fnins.2022.974096
|
[25] |
Ya JY,Zhou D,Ding JY,et al. High-resolution combined arterial spin labeling MR for identifying cerebral arterial stenosis induced by moyamoya disease or atherosclerosis[J]. Ann Transl Med,2020,8(4): 87. doi: 10.21037/atm.2019.12.140
|
[26] |
Tsivgoulis G,Katsanos AH,Sharma VK,et al. Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke[J]. Neurology,2016,86(12): 1103-1111. doi: 10.1212/WNL.0000000000002493
|
[27] |
Malhotra K,Safouris A,Goyal N,et al. Association of statin pretreatment with collateral circulation and final infarct volume in acute ischemic stroke patients:a meta-analysis[J]. Atherosclerosis,2019,282: 75-79. doi: 10.1016/j.atherosclerosis.2019.01.006
|
[28] |
Li WX,Wei D,Xie XM,et al. Dl-3-n-Butylphthalide regulates the Ang-1/Ang-2/Tie-2 signaling axis to promote neovascularization in chronic cerebral hypoperfusion[J]. Biomedecine Pharmacother,2019,113: 108757. doi: 10.1016/j.biopha.2019.108757
|
[29] |
Wang JH,Li YY,Yu HH,et al. Dl-3-N-butylphthalide promotes angiogenesis in an optimized model of transient ischemic attack in C57BL/6 mice[J]. Front Pharmacol,2021,12: 751397. doi: 10.3389/fphar.2021.751397
|
[30] |
Zhao HR,Yun WW,Zhang QY,et al. Mobilization of circulating endothelial progenitor cells by dl-3-n-butylphthalide in acute ischemic stroke patients[J]. J Stroke Cerebrovasc Dis,2016,25(4): 752-760. doi: 10.1016/j.jstrokecerebrovasdis.2015.11.018
|
[31] |
欧阳欣,胡巧霞,高大鹏. 丁苯酞注射液对急性脑梗死合并颅内动脉狭窄患者颅内动脉血流动力学、氧化应激及血清Hcy和CysC水平的影响[J]. 中国老年学杂志,2020,40(12): 2485-2487. doi: 10.3969/j.issn.1005-9202.2020.12.006
|
[32] |
Kimmel ER,Al Kasab S,Harvey JB,et al. Absence of collaterals is associated with larger infarct volume and worse outcome in patients with large vessel occlusion and mild symptoms[J]. J Stroke Cerebrovasc Dis,2019,28(7): 1987-1992. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.032
|
[33] |
Kuroda S,Nakayama N,Yamamoto S,et al. Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease[J]. J Neurosurg,2020,134(3): 909-916.
|
[34] |
Kim DY,Son JP,Yeon JY,et al. Infarct pattern and collateral status in adult moyamoya disease:a multimodal magnetic resonance imaging study[J]. Stroke,2017,48(1): 111-116. doi: 10.1161/STROKEAHA.116.014529
|
[35] |
Lai PMR,Gomez-Paz S,Patel NJ,et al. Asymptomatic moyamoya disease in a North American adult cohort[J]. World Neurosurg,2022,161: e146-e153. doi: 10.1016/j.wneu.2022.01.076
|